Document

Opportunity for Licensing: Vasostatin, an Inhibitor of Endothelial Cell Growth and Angiogenesis

[Federal Register Volume 64, Number 143 (Tuesday, July 27, 1999)] [Corrections] [Page 40651] From the Federal Register Online via the Government Publishing Office [ www.gpo.gov ...

[Federal Register Volume 64, Number 143 (Tuesday, July 27, 1999)]
[Corrections]
[Page 40651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C9-18377]



Federal Register / Vol. 64, No. 143 / Tuesday, July 27?, 1999 / 
Corrections

[[Page 40651]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Opportunity for Licensing: Vasostatin, an Inhibitor of 
Endothelial Cell Growth and Angiogenesis

Correction

    In notice document 99-18377, appearing on page 38686, in the issue 
of Monday, July 19, 1999, make the following corrections:
    1. The subject line should appear as set forth above.
    2. In the first column, under SUMMARY, in the tenth line, ``at'' 
should read ``a''.
[FR Doc. C9-18377 Filed 7-26-99; 8:45 am]
BILLING CODE 1505-01-D


Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

64 FR 40651

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Opportunity for Licensing: Vasostatin, an Inhibitor of Endothelial Cell Growth and Angiogenesis,” thefederalregister.org (July 27, 1999), https://thefederalregister.org/documents/C9-18377/opportunity-for-licensing-vasostatin-an-inhibitor-of-endothelial-cell-growth-and-angiogenesis.